Tag: cannabis
-
The Curious Case of Maple Leaf Green World (MGW.C)
Long time readers will remember the weird ass name of Maple Leaf Green World (MGW.C) from several years back in the cannabis space, when a group arrived from China determined to make their riches in the North American weed fields, only to end up in a small, dank, broken down greenhouse in Nevada, under a…
-
BC Bud Corp (BCBC.C) breathes new life into the cannabis space, up 3x in two months
I told you. Then I told you again. I know it’s uncouth to say “I told you so,” but I did, didn’t I? BC Bud Corporation (BCBC.C) has jumped to $0.05, up from $0.015 two months ago, even while closing a raise priced at $0.02. BCBC boss Brayden Sutton, who has been a cannabis behind-the-scenes…
-
Weed roll-up BZAM (BZAM.C) used stock to buy assets <60 days before asking for creditor protection
You’ve built a decent little company. You’ve grown some brands. You’re feeling okay about things when a bigger company comes along, offers you a bunch of their stock, making you a significant shareholder, and tells you there are other strong hands in the investor base, including the wealthy chairman who has been lending the company…
-
![Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets]()
Bionxt Solutions (BNXT.C) shows how pivots don’t have to mean resets
Several years back, Hugh Rogers was in my office talking about his cannabis company. Way back then, the plan was to grow in Germany and be first on the continent, using an old wartime bunker as a ‘safe growing facility’. Those plans morphed quickly as the reality of the cannabis space became clear. The cannabis…
-
![Revive Therapeutics (RVV.C) finds multiple research options moving forward]()
Revive Therapeutics (RVV.C) finds multiple research options moving forward
In Canada, if you look backwards over the timeline, you’ll often find public companies have been other things back in the day. Risen, fallen, tapped out, rolled back, reemerged as a whole new thing. Sometimes this happens several times before a business model catches. Revive Therapeutics (RVV.C) is that rare Canadian smallcap that, while it…
-
![Stately’s long road to public finally finds an onramp with Gold Flora/TCPO (GRAM.NEO)]()
Stately’s long road to public finally finds an onramp with Gold Flora/TCPO (GRAM.NEO)
Good things happen in sunny Costa Mesa, California and, today, one of those good things happened for a certain group of cannabis investors. Longtime readers may recall Trent Kitsch, who founded Doja Cannabis (which would be consumed by Canopy Growth Corp for $400m), had bounced to his next venture not long after that deal closed…
-
![Stocks to Watch: Lexaria Bioscience (LEXX.Q) sees gains]()
Stocks to Watch: Lexaria Bioscience (LEXX.Q) sees gains
Special Delivery Lexaria Bioscience Corp. (LEXX.Q) is a biotechnology company developing DehydraTECH™, the Company’s proprietary drug delivery technology. In addition to enhancing the speed and efficiency of orally-delivered drugs, DehydraTECH has demonstrated effectiveness in improving delivery through human skin for the potential development of topically-administered products such as patches. Through various animal studies evaluating the quantity…
-
![If I had a billion dollars: the cannabis edition, Chris Parry’s Infamous Dad Talk, Hexo (HEXO.T), GrowGeneration (GRWG.NASDAQ), Sundial (SNDL.NASDAQ)]()
If I had a billion dollars: the cannabis edition, Chris Parry’s Infamous Dad Talk, Hexo (HEXO.T), GrowGeneration (GRWG.NASDAQ), Sundial (SNDL.NASDAQ)
In early 2018, Equity Guru had 30 cannabis clients. At the time, it was our specialty, our niche. Equity Guru owner Chris Parry was the one of the first journalists to take the sector seriously. Later, we signed a bioscience accelerator (XPhyto Therapeutics (XPHY.C), a concealed weapon detector co. (Patriot One (PAT.T) and a grocery…
-
![What’s Going On In Cannabis: A Mini Roundup]()
What’s Going On In Cannabis: A Mini Roundup
The overall health of the cannabis sector still isn’t good. Think crypto and blockchain in the winter of 2018 and you get an idea of what we’re looking at. Getting into the weeds on this one eliminated a few of my suspicions about what might be causing it—there isn’t an exorbitant amount of companies drowning…
-
![Canntab Therapeutics (PILL.C) Enters Agreement with 36Eight Technologies]()
Canntab Therapeutics (PILL.C) Enters Agreement with 36Eight Technologies
Canntab Therapeutics (PILL.C) announced today that it has reached an agreement with 36Eight Technologies (“36Eight”), whereby “36Eight” will list, market, and support all of Canntab’s market-exclusive and patent-protected solid and exact dose products. “This is an exciting opportunity for Canntab, as we believe 36Eight’s unique and valuable complementary platform will support our ability to provide…
